Revolutions Medical: Major breakthrough in automatic retractable prefilled safety syringe technology

Revolutions Medical Corporation announces a major breakthrough in automatic retractable prefilled safety syringe technology. Building on the Company's proprietary vacuum based technology, important improvements in performance have been made that will set a new gold standard for safety in automatic prefilled syringes. The enhanced technology will provide for a level of passive protection from needle stick injury that is unmatched in the industry. Because of the small number of parts, longer shelf life, and elegance of the vacuum design, the price point will be far below that of any competitive prefilled safety syringe technology currently on the market.

"Our new prefilled auto retractable vacuum safety syringe designs will allow us to compete in another part of the market that has tremendous growth. We will be filing additional patents shortly to protect and expand our new prefilled syringe technologies. There is potential to form strategic partnerships with one or more pharmaceutical companies to provide a better prefilled syringe to deliver their products than currently exists," states Ron Wheet, CEO of Revolutions Medical.

Almost 50 injectable drug products are currently supplied in prefilled syringes. Combined, these drugs achieved annual sales of approximately $45 billion in 2007. Prefilled syringes offer significant financial and industrial benefits to pharmaceutical companies in areas such as reduced dose wastage and improved drug marketability to healthcare workers, and patients who self-administer prescribed medication at home. Due to such growth drivers, we expect that more than 3 billion prefilled syringes will be manufactured globally in 2011.

The company is still on schedule to ship its first 3ml RevVac fixed needle safety syringes in April and its first 1ml RevVac fixed needle safety syringes in July 2011 from its manufacturer in China. Revolutions Medical will have final production samples and take its first orders from distributors by mid-March.